PCOS Screening & Assessment

Florya uses the Rotterdam Protocol — the international diagnostic standard — to assess three key criteria: hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphology indicators. Our questionnaire captures symptom patterns while lab results provide biomarker confirmation.

Our assessment classifies PCOS into four phenotypes (Types A-D) based on which Rotterdam criteria are present. Type A (Classic) shows all three criteria, while Type D shows only polycystic morphology and ovulatory dysfunction. This classification helps your physician tailor treatment.

Florya provides clinical screening, not a medical diagnosis. Our assessment generates a risk score and evidence summary that your healthcare provider can use to guide further investigation and formal diagnosis.

Based on your symptom profile, Florya may recommend testing AMH, LH, FSH, Total and Free Testosterone, DHEA-S, SHBG, and Fasting Insulin. These markers help confirm hyperandrogenism and metabolic involvement.

PCOS is classified into four phenotypes using the Rotterdam criteria: Type A (Classic/Full) presents with all three criteria — hyperandrogenism, ovulatory dysfunction, and polycystic morphology. Type B shows hyperandrogenism and ovulatory dysfunction without polycystic morphology. Type C presents with hyperandrogenism and polycystic morphology but regular ovulation. Type D shows ovulatory dysfunction and polycystic morphology without hyperandrogenism.

Yes. PCOS is an endocrine (hormonal) disorder characterized by excess androgens (male hormones), irregular ovulation, and metabolic dysfunction. It often involves insulin resistance, which drives further hormonal imbalance. Treatment approaches address both the hormonal and metabolic components.

Clinical screening using the Rotterdam Protocol can identify PCOS risk through symptom assessment and biomarker analysis (AMH, LH/FSH ratio, testosterone, insulin) without requiring ultrasound. While ultrasound confirms polycystic ovarian morphology, two of the three Rotterdam criteria can be assessed through clinical and biochemical evaluation alone.